These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 9658722

  • 1. CD27 in B-cell chronic lymphocytic leukemia. Cellular expression, serum release and correlation with other soluble molecules belonging to nerve growth factor receptors (NGFr) superfamily.
    Molica S, Vitelli G, Levato D, Crispino G, Dell'Olio M, Dattilo A, Matera R, Gandolfo GM, Musto P.
    Haematologica; 1998 May; 83(5):398-402. PubMed ID: 9658722
    [Abstract] [Full Text] [Related]

  • 2. Metalloprotease inhibitors block release of soluble CD27 and enhance the immune stimulatory activity of chronic lymphocytic leukemia cells.
    Kato K, Chu P, Takahashi S, Hamada H, Kipps TJ.
    Exp Hematol; 2007 Mar; 35(3):434-42. PubMed ID: 17309824
    [Abstract] [Full Text] [Related]

  • 3. Clinico-biological implications of increased serum levels of interleukin-8 in B-cell chronic lymphocytic leukemia.
    Molica S, Vitelli G, Levato D, Levato L, Dattilo A, Gandolfo GM.
    Haematologica; 1999 Mar; 84(3):208-11. PubMed ID: 10189383
    [Abstract] [Full Text] [Related]

  • 4. Cellular expression and serum circulating levels of CD23 in B-cell chronic lymphocytic leukemia. Implications for prognosis.
    Molica S, Levato D, Dell'Olio M, Matera R, Minervini M, Dattilo A, Carotenuto M, Musto P.
    Haematologica; 1996 Mar; 81(5):428-33. PubMed ID: 8952156
    [Abstract] [Full Text] [Related]

  • 5. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
    Molica S, Vitelli G, Mirabelli R, Digiesu G, Giannarelli D, Cuneo A, Ribatti D, Vacca A.
    Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
    [Abstract] [Full Text] [Related]

  • 6. Increased levels of soluble CD27 in the cerebrospinal fluid are not diagnostic for leptomeningeal involvement by lymphoid malignancies.
    van den Bent MJ, Lamers CH, van 't Veer MB, Sillevis Smitt PA, Bolhuis RL, Gratama JW.
    Ann Hematol; 2002 Apr; 81(4):187-91. PubMed ID: 11976819
    [Abstract] [Full Text] [Related]

  • 7. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
    Bojarska-Junak A, Rolinski J, Wasik-Szczepaneko E, Kaluzny Z, Dmoszynska A.
    Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
    [Abstract] [Full Text] [Related]

  • 8. Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma.
    Widney D, Gundapp G, Said JW, van der Meijden M, Bonavida B, Demidem A, Trevisan C, Taylor J, Detels R, Martínez-Maza O.
    Clin Immunol; 1999 Nov; 93(2):114-23. PubMed ID: 10527687
    [Abstract] [Full Text] [Related]

  • 9. B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules.
    Trentin L, Zambello R, Sancetta R, Facco M, Cerutti A, Perin A, Siviero M, Basso U, Bortolin M, Adami F, Agostini C, Semenzato G.
    Cancer Res; 1997 Nov 01; 57(21):4940-7. PubMed ID: 9354461
    [Abstract] [Full Text] [Related]

  • 10. High levels of serum soluble CD27 correlated with renal dysfunction.
    Nakatsuji T.
    Clin Exp Med; 2003 Feb 01; 2(4):192-6. PubMed ID: 12624711
    [Abstract] [Full Text] [Related]

  • 11. Comparative flow cytometric evaluation of bcl-2 oncoprotein in CD5+ and CD5- B-cell lymphoid chronic leukemias.
    Molica S, Mannella A, Crispino G, Dattilo A, Levato D.
    Haematologica; 1997 Feb 01; 82(5):555-9. PubMed ID: 9407720
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of biological variables in B-cell chronic lymphocytic leukemia. Can we improve upon clinical parameters?
    Molica S.
    Haematologica; 1997 Feb 01; 82(6):705-9. PubMed ID: 9499672
    [Abstract] [Full Text] [Related]

  • 13. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
    Kusenda J, Babusíková O.
    Neoplasma; 2004 Feb 01; 51(2):97-102. PubMed ID: 15190418
    [Abstract] [Full Text] [Related]

  • 14. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
    Hojjat Farsangi M, Jeddi-Tehrani M, Razavi SM, Sharifian RA, Shamsian Khoramabadi A, Rabbani H, Shokri F.
    Iran J Immunol; 2008 Mar 01; 5(1):25-35. PubMed ID: 18319522
    [Abstract] [Full Text] [Related]

  • 15. Clinico-prognostic implications of increased levels of soluble CD54 in the serum of B-cell chronic lymphocytic leukemia patients. Results of a multivariate survival analysis.
    Molica S, Levato D, Dell' Olio M, Cascavilla N, Matera R, Minervini M, Dattilo A, Carotenuto M, Musto P.
    Haematologica; 1997 Mar 01; 82(2):148-51. PubMed ID: 9175316
    [Abstract] [Full Text] [Related]

  • 16. Expression of thrombospondin receptor (CD36) in B-cell chronic lymphocytic leukemia as an indicator of tumor cell dissemination.
    Rutella S, Rumi C, Puggioni P, Barberi T, Di Mario A, Larocca LM, Leone G.
    Haematologica; 1999 May 01; 84(5):419-24. PubMed ID: 10329920
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia.
    Lai R, O'Brien S, Maushouri T, Rogers A, Kantarjian H, Keating M, Albitar M.
    Cancer; 2002 Sep 01; 95(5):1071-5. PubMed ID: 12209693
    [Abstract] [Full Text] [Related]

  • 18. Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia.
    Ibrahim S, Jilani I, O'Brien S, Rogers A, Manshouri T, Giles F, Faderl S, Thomas D, Kantarjian H, Keating M, Albitar M.
    Cancer; 2003 Apr 15; 97(8):1914-9. PubMed ID: 12673718
    [Abstract] [Full Text] [Related]

  • 19. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia.
    Wolowiec D, Ciszak L, Kosmaczewska A, Bocko D, Teodorowska R, Frydecka I, Kuliczkowski K.
    Haematologica; 2001 Dec 15; 86(12):1296-304. PubMed ID: 11726322
    [Abstract] [Full Text] [Related]

  • 20. Soluble form of TRAIL, Fas and FasL in the serum of patients with B-CLL.
    Jabłońska E, Kiersnowska-Rogowska B, Rogowski F, Parfieńczyk A, Puzewska W, Bukin M.
    Rocz Akad Med Bialymst; 2005 Dec 15; 50():204-7. PubMed ID: 16358967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.